JITC

Immunotherapeutic approaches to ovarian cancer treatment
Cariad Chester, Oliver Dorigo, Jonathan S Berek, Holbrook Kohrt

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 7; DOI: 10.1186/s40425-015-0051-7
JITC launches a new section: commentary and editorials
Christian M. Capitini, Pedro Romero

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 28; DOI: 10.1186/s40425-015-0073-1
Immune monitoring technology primer: clinical validation for predictive markers
Kevin K. Dobbin

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 40; DOI: 10.1186/s40425-015-0086-9
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
Elias J Sayour, Luis Sanchez-Perez, Catherine Flores, Duane A Mitchell

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 13; DOI: 10.1186/s40425-015-0058-0
Immune monitoring technology primer: immunosequencing
Ilan Kirsch

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 29; DOI: 10.1186/s40425-015-0076-y
Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients
Jithendra Kini Bailur, Evelyna Derhovanessian, Brigitte Gueckel, Graham Pawelec

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 45; DOI: 10.1186/s40425-015-0090-0
Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model
Michael D Roth, Airi Harui

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 12; DOI: 10.1186/s40425-015-0056-2
Target discovery for T cell therapy: next steps to advance Immunotherapies
Adrian Bot, Joanna E Brewer, Zelig Eshhar, Stanley R Frankel, Emma Hickman, Achim A Jungbluth, Richard Morgan, Yoav Peretz, Laszlo Radvanyi, Carlos A Ramos, Paul F Robbins, Kai W Wucherpfennig

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 31; DOI: 10.1186/s40425-015-0061-5
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
Zipei Feng, Sachin Puri, Tarsem Moudgil, William Wood, Clifford C. Hoyt, Chichung Wang, Walter J. Urba, Brendan D. Curti, Carlo B. Bifulco, Bernard A. Fox

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 47; DOI: 10.1186/s40425-015-0091-z
Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
Asim Amin, Arkadiusz Z Dudek, Theodore F Logan, Raymond S Lance, Jeffrey M Holzbeierlein, Jennifer J Knox, Viraj A Master, Sumanta K Pal, Wilson H Miller, Lawrence I Karsh, Irina Y Tcherepanova, Mark A DeBenedette, W Lee Williams, Douglas C Plessinger, Charles A Nicolette, Robert A Figlin

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 14; DOI: 10.1186/s40425-015-0055-3

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages